Clinical Trial Update: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

View source ↗

Summary

A terminated clinical trial evaluated the safety of risperidone in obese or overweight patients with schizophrenia or schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen-Cilag, S.A. | Conditions: Schizophrenia, Schizoaffective Disorder | Status: TERMINATED